🇺🇸 FDA
Pipeline program

Empagliflozin 10 MG

EMPATHY

Phase 3 small_molecule active

Quick answer

Empagliflozin 10 MG for Acute Decompensated Heart Failure is a Phase 3 program (small_molecule) at COLLEGIUM PHARMACEUTICAL, INC with 1 ClinicalTrials.gov record(s).

Program details

Company
COLLEGIUM PHARMACEUTICAL, INC
Indication
Acute Decompensated Heart Failure
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials